Stimulation of subthalamic nucleus for parkinsons disease

Takashi Agari, Isao Date

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Subthalamic stimulation (STN-DBS) is an established treatment for the patients with advanced Parkinson’s disease (PD). It is considered a surgical treatment alternative for patients with intractable tremor or for those patients who are affected by long-term complications of levodopa therapy such as motor fluctuations and severe dyskinesias. The response to levodopa is a good prognostic factor for good therapeutic effect of STN-DBS. STN-DBS improves the off-period motor symptom and dyskinesias and allows to reduce the levodopa dose, to shorten the off-period and to improve activities of daily livings and quality of life of PD patients. Treatment timing of STN-DBS may be better to start from a relatively early stage of motor fluctuation to emerge to keep the QOL of patients with good long-term conditions. It is said that there is a possibility of causing a decline in cognition after STN-DBS. By performing the surgery with high accuracy, it may be possible to minimize complications of STN-DBS.

Original languageEnglish
Title of host publicationDeep Brain Stimulation for Neurological Disorders: Theoretical Background and Clinical Application
PublisherSpringer International Publishing
Pages73-86
Number of pages14
ISBN (Print)9783319084763, 9783319084756
DOIs
Publication statusPublished - Jan 1 2015

Fingerprint

Subthalamic Nucleus
Parkinson Disease
Levodopa
Dyskinesias
Tremor
Therapeutic Uses
Therapeutics
Activities of Daily Living
Cognition
Quality of Life

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Agari, T., & Date, I. (2015). Stimulation of subthalamic nucleus for parkinsons disease. In Deep Brain Stimulation for Neurological Disorders: Theoretical Background and Clinical Application (pp. 73-86). Springer International Publishing. https://doi.org/10.1007/978-3-319-08476-3-7

Stimulation of subthalamic nucleus for parkinsons disease. / Agari, Takashi; Date, Isao.

Deep Brain Stimulation for Neurological Disorders: Theoretical Background and Clinical Application. Springer International Publishing, 2015. p. 73-86.

Research output: Chapter in Book/Report/Conference proceedingChapter

Agari, T & Date, I 2015, Stimulation of subthalamic nucleus for parkinsons disease. in Deep Brain Stimulation for Neurological Disorders: Theoretical Background and Clinical Application. Springer International Publishing, pp. 73-86. https://doi.org/10.1007/978-3-319-08476-3-7
Agari T, Date I. Stimulation of subthalamic nucleus for parkinsons disease. In Deep Brain Stimulation for Neurological Disorders: Theoretical Background and Clinical Application. Springer International Publishing. 2015. p. 73-86 https://doi.org/10.1007/978-3-319-08476-3-7
Agari, Takashi ; Date, Isao. / Stimulation of subthalamic nucleus for parkinsons disease. Deep Brain Stimulation for Neurological Disorders: Theoretical Background and Clinical Application. Springer International Publishing, 2015. pp. 73-86
@inbook{c176f939a5a84463acc43badc355a7de,
title = "Stimulation of subthalamic nucleus for parkinsons disease",
abstract = "Subthalamic stimulation (STN-DBS) is an established treatment for the patients with advanced Parkinson’s disease (PD). It is considered a surgical treatment alternative for patients with intractable tremor or for those patients who are affected by long-term complications of levodopa therapy such as motor fluctuations and severe dyskinesias. The response to levodopa is a good prognostic factor for good therapeutic effect of STN-DBS. STN-DBS improves the off-period motor symptom and dyskinesias and allows to reduce the levodopa dose, to shorten the off-period and to improve activities of daily livings and quality of life of PD patients. Treatment timing of STN-DBS may be better to start from a relatively early stage of motor fluctuation to emerge to keep the QOL of patients with good long-term conditions. It is said that there is a possibility of causing a decline in cognition after STN-DBS. By performing the surgery with high accuracy, it may be possible to minimize complications of STN-DBS.",
author = "Takashi Agari and Isao Date",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/978-3-319-08476-3-7",
language = "English",
isbn = "9783319084763",
pages = "73--86",
booktitle = "Deep Brain Stimulation for Neurological Disorders: Theoretical Background and Clinical Application",
publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Stimulation of subthalamic nucleus for parkinsons disease

AU - Agari, Takashi

AU - Date, Isao

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Subthalamic stimulation (STN-DBS) is an established treatment for the patients with advanced Parkinson’s disease (PD). It is considered a surgical treatment alternative for patients with intractable tremor or for those patients who are affected by long-term complications of levodopa therapy such as motor fluctuations and severe dyskinesias. The response to levodopa is a good prognostic factor for good therapeutic effect of STN-DBS. STN-DBS improves the off-period motor symptom and dyskinesias and allows to reduce the levodopa dose, to shorten the off-period and to improve activities of daily livings and quality of life of PD patients. Treatment timing of STN-DBS may be better to start from a relatively early stage of motor fluctuation to emerge to keep the QOL of patients with good long-term conditions. It is said that there is a possibility of causing a decline in cognition after STN-DBS. By performing the surgery with high accuracy, it may be possible to minimize complications of STN-DBS.

AB - Subthalamic stimulation (STN-DBS) is an established treatment for the patients with advanced Parkinson’s disease (PD). It is considered a surgical treatment alternative for patients with intractable tremor or for those patients who are affected by long-term complications of levodopa therapy such as motor fluctuations and severe dyskinesias. The response to levodopa is a good prognostic factor for good therapeutic effect of STN-DBS. STN-DBS improves the off-period motor symptom and dyskinesias and allows to reduce the levodopa dose, to shorten the off-period and to improve activities of daily livings and quality of life of PD patients. Treatment timing of STN-DBS may be better to start from a relatively early stage of motor fluctuation to emerge to keep the QOL of patients with good long-term conditions. It is said that there is a possibility of causing a decline in cognition after STN-DBS. By performing the surgery with high accuracy, it may be possible to minimize complications of STN-DBS.

UR - http://www.scopus.com/inward/record.url?scp=84955087099&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955087099&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-08476-3-7

DO - 10.1007/978-3-319-08476-3-7

M3 - Chapter

AN - SCOPUS:84955087099

SN - 9783319084763

SN - 9783319084756

SP - 73

EP - 86

BT - Deep Brain Stimulation for Neurological Disorders: Theoretical Background and Clinical Application

PB - Springer International Publishing

ER -